Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.47 | -22.08 |
| PEG Ratio (TTM) | 0.10 | 15.66 |
| P/S Ratio (TTM) | 2.46 | 49.38 |
| P/B Ratio (TTM) | 0.50 | 18.85 |
| P/FCF Ratio (TTM) | -1.34 | -3.07 |
| Price to 5YR AVG Earnings Ratio | -0.33 | -3.42 |
| Price to 5YR AVG FCF Ratio | -1.87 | -9.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -55.23% | -5.15% |
| ROE (TTM) | -86.10% | 16.37% |
| Net Profit Margin (TTM) | -486.98% | -2,030.32% |
| ROIC 5YR AVG | -507.66% | 15.65% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -50.19% | -20,971.66% | -13,393.18% |
| Revenue | -2.80% | 123.93% | 70.06% |
| Net Income | -13.48% | -452.30% | -261.70% |
| Cash Flow | -11.11% | -73.87% | -47.63% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.71 | 6.19 |
| Quick Ratio (TTM) | 4.71 | 5.91 |
| D/E Ratio (TTM) | 0.54 | -15.10 |
| Interest Coverage (TTM) | -8,065.74 | -1.60 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 14.02 |
| LTL to 5YR AVG FCF | -0.92 | 0.18 |
| Shares Outstanding Growth 5YR AVG | 897.06% | 123.85% |